443 related articles for article (PubMed ID: 7541801)
1. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.
De Bellis A; Bizzarro A; Gattoni A; Romano C; Di Martino S; Sinisi AA; Abbadessa S; Bellastella A
J Clin Endocrinol Metab; 1995 Jul; 80(7):2118-21. PubMed ID: 7541801
[TBL] [Abstract][Full Text] [Related]
2. [Soluble forms of adhesion molecules sELAM-1 and sICAM-1 in Graves disease and toxic nodular goiter].
Modelska-Ziółkiewicz A; Gembicki M; Sowiński J
Pol Arch Med Wewn; 2003 May; 109(5):463-8. PubMed ID: 14768174
[TBL] [Abstract][Full Text] [Related]
3. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy.
De Bellis A; Di Martino S; Fiordelisi F; Muccitelli VI; Sinisi AA; Abbate GF; Gargano D; Bellastella A; Bizzarro A
J Clin Endocrinol Metab; 1998 Apr; 83(4):1222-5. PubMed ID: 9543145
[TBL] [Abstract][Full Text] [Related]
4. Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy.
Wakelkamp IM; Gerding MN; van der Meer JW; Prummel MF; Wiersinga WM
Clin Exp Immunol; 2002 Feb; 127(2):316-20. PubMed ID: 11876756
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic role of adhesion molecules sELAM-1 and sICAM-1 in glucocorticoid therapy of active ophthalmopathy].
Modelska-Ziółkiewicz A; Gembicki M; Bednarek J; Sowiński J
Pol Arch Med Wewn; 2003 May; 109(5):469-75. PubMed ID: 14768175
[TBL] [Abstract][Full Text] [Related]
6. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
[TBL] [Abstract][Full Text] [Related]
7. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.
Wenisch C; Myskiw D; Gessl A; Graninger W
J Clin Endocrinol Metab; 1995 Jul; 80(7):2122-6. PubMed ID: 7541802
[TBL] [Abstract][Full Text] [Related]
8. Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves' disease with or without ophthalmopathy.
Ozata M; Bolu E; Sengül A; Altinsoy HI; Turan M; Corakci A; Hacibektasoglu A; Gundogan MA
Endocr J; 1996 Oct; 43(5):517-25. PubMed ID: 8980891
[TBL] [Abstract][Full Text] [Related]
9. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases.
Heufelder AE; Bahn RS
Clin Exp Immunol; 1993 May; 92(2):296-302. PubMed ID: 8097976
[TBL] [Abstract][Full Text] [Related]
10. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease.
Balázs C; Kiss E
Acta Microbiol Immunol Hung; 1994; 41(4):451-6. PubMed ID: 7866729
[TBL] [Abstract][Full Text] [Related]
11. Soluble endothelium-associated adhesion molecules in patients with Graves' disease.
Wenisch C; Myskiw D; Parschalk B; Hartmann T; Dam K; Graninger W
Clin Exp Immunol; 1994 Nov; 98(2):240-4. PubMed ID: 7525128
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of soluble E selectin levels in patients with Graves' disease and thyroid orbitopathy].
Kulig G; Pilarska K; Kulig J; Robaczyk M; Gromniak E
Przegl Lek; 2004; 61(12):1314-8. PubMed ID: 15850320
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of soluble ICAM-1 measurements for the evaluation of the disease activity and efficiency of therapy in patients with infiltrative Graves' ophthalmopathy].
Kulig G; Pilarska K; Kulig J; Krzyzanowska-Swiniarska B; Robaczyk M; Baraniak A
Pol Arch Med Wewn; 2002 Dec; 108(6):1161-9. PubMed ID: 12687928
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment.
Kowalzick L; Kleinheinz A; Neuber K; Weichenthal M; Köhler I; Ring J
Dermatology; 1995; 190(1):14-8. PubMed ID: 7534511
[TBL] [Abstract][Full Text] [Related]
15. Intercellular adhesion molecule-1 (ICAM-1) in the sera of patients with Graves' disease: correlation with disease activity and treatment status.
Fukazawa H; Yoshida K; Kaise N; Kiso Y; Sayama N; Mori K; Kikuchi K; Aizawa Y; Rikimaru A; Abe K
Thyroid; 1995 Oct; 5(5):373-7. PubMed ID: 8563475
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity.
Jakobsen PH; Morris-Jones S; Rønn A; Hviid L; Theander TG; Elhassan IM; Bygbjerg IC; Greenwood BM
Immunology; 1994 Dec; 83(4):665-9. PubMed ID: 7533138
[TBL] [Abstract][Full Text] [Related]
17. [The role od adhesion molecules in the pathogenesis of Graves ophthalmopathy].
Kulig G; Pilarska K
Klin Oczna; 2001; 103(2-3):147-50. PubMed ID: 11873415
[TBL] [Abstract][Full Text] [Related]
18. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
19. [Serum levels of adhesion molecules (sICAM-1, sVCAM-1 and sP-selectin) in children and adolescents with thyroid diseases].
Bossowski A; Urban M; Citko A; Sobotko J; Bossowska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2000; 6(2):79-92. PubMed ID: 12818068
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease.
Sonnet E; Massart C; Gibassier J; Allannic H; Maugendre D
J Endocrinol Invest; 1999 Jun; 22(6):430-5. PubMed ID: 10435852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
